Literature DB >> 19563778

Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential.

Yen-Sung Huang1, Hsiu-Ming Shih.   

Abstract

Constitutive activation of the transcription factor TCF4 activity by mutated APC or beta-catenin contributes to cell neoplastic transformation. While numerous proteins were identified to activate TCF4-dependent activity via beta-catenin interaction, little is known about factors directly acting on TCF4. Here we report that Daxx binds to TCF4 and potentiates beta-catenin/TCF4-mediated transcriptional activation and target gene expression. Binding studies revealed that Daxx-TCF4 interaction is through the C-terminal domain of Daxx and TCF4 segment containing amino acid residue 269-327. Alteration of Daxx levels in cells by overexpression or RNA interference resulted in an increase or decrease of the beta-catenin/TCF4-dependent transactivation activity and target gene expression, respectively. Furthermore, TCF4-(269-327) segment acts as a dominantly negative mutant by blocking Daxx-TCF4 interaction and TCF4-mediated transactivation potential. Together, our results suggest that Daxx functions as a positive coregulator in modulating the beta-catenin/TCF4-dependent transcriptional potential via TCF4 interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563778     DOI: 10.1016/j.bbrc.2009.06.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.

Authors:  Yung-Lin Hsieh; Hong-Yi Kuo; Che-Chang Chang; Mandar T Naik; Pei-Hsin Liao; Chun-Chen Ho; Tien-Chi Huang; Jen-Chong Jeng; Pang-Hung Hsu; Ming-Daw Tsai; Tai-Huang Huang; Hsiu-Ming Shih
Journal:  EMBO J       Date:  2013-02-08       Impact factor: 11.598

2.  Transcription factor TCF4 maintains the properties of human corneal epithelial stem cells.

Authors:  Rong Lu; Yangluowa Qu; Jian Ge; Lili Zhang; Zhitao Su; Stephen C Pflugfelder; De-Quan Li
Journal:  Stem Cells       Date:  2012-04       Impact factor: 6.277

3.  Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.

Authors:  Eric Escobar-Cabrera; Mark Okon; Desmond K W Lau; Christopher F Dart; Alexandre M J J Bonvin; Lawrence P McIntosh
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

4.  Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth.

Authors:  Yen-Sung Huang; Chang-Chieh Wu; Che-Chang Chang; Shiu-Feng Huang; Hong-Yi Kuo; Hsiu-Ming Shih
Journal:  Cell Mol Life Sci       Date:  2022-06-19       Impact factor: 9.207

5.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 6.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

7.  Berberine represses DAXX gene transcription and induces cancer cell apoptosis.

Authors:  Jiansha Li; Lubing Gu; Hailong Zhang; Tao Liu; Dan Tian; Muxiang Zhou; Sheng Zhou
Journal:  Lab Invest       Date:  2013-01-07       Impact factor: 5.662

8.  Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.

Authors:  Gu-Jiun Lin; Yen-Sung Huang; Chih-Kung Lin; Shing-Hwa Huang; Hsiu-Ming Shih; Huey-Kang Sytwu; Yuan-Wu Chen
Journal:  Clin Oral Investig       Date:  2015-07-24       Impact factor: 3.573

Review 9.  DAXX in cancer: phenomena, processes, mechanisms and regulation.

Authors:  Iqbal Mahmud; Daiqing Liao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

Review 10.  The regulation of β-catenin activity and function in cancer: therapeutic opportunities.

Authors:  Shuang Shang; Fang Hua; Zhuo-Wei Hu
Journal:  Oncotarget       Date:  2017-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.